- cafead   Jul 21, 2022 at 10:02: PM
via The former R&D head of GSK’s vaccine unit is going toe-to-toe with his former employer, launching a rival vaccine-centered biotech that’s immediately challenging one of the U.K. pharma's late-stage programs.
article source
article source